1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsFull proposals accepted anytime on a rolling basis.
Engineering Biological and Biomedical Systems (EBBS) is sponsored by U.S. National Science Foundation. The Engineering Biological and Biomedical Systems (EBBS) program expands the understanding of biological and physiological systems and helps improve human health.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Engineering Biological and Biomedical Systems | NSF - U.S. National Science Foundation Engineering Biological and Biomedical Systems Important proposal submission information Proposals for this program currently must be submitted through Research. gov by selecting NSF 24-1 - NSF Proposal & Award Policies & Procedures Guide (PAPPG) as the funding opportunity.
Under NSF 24-1, select Directorate for Engineering (ENG); Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET); and the program name. Proposals for this program cannot currently be submitted through Grants.
gov. Important information for proposers and award recipients All proposals must be submitted in accordance with the requirements specified in the funding opportunity and in the Proposal & Award Policies & Procedures Guide (PAPPG) and its supplements . All NSF grants and cooperative agreements are subject to the applicable set of NSF award terms and conditions . NSF has updated its research security policies for NSF funded projects.
Supports engineering research on platforms, devices, organisms, tissues and processes that advance knowledge and control of biological functions. Supports engineering research on platforms, devices, organisms, tissues and processes that advance knowledge and control of biological functions.
The Engineering Biological and Biomedical Systems (EBBS) program expands our understanding of biological and physiological systems, and it helps improve human health. For U.S. leadership in biotechnology, the engineering of biology is required at every scale. Engineering is needed for sensing biomarkers to making proteins to restoring functions of the body.
In EBBS, fundamental mechanistic insights are combined with experimental and computational techniques. This approach helps develop platforms, devices, organisms, tissues, and processes that bring new understanding and control of biological functions. EBBS supports studies of mechanisms that drive the behavior of microbial populations and cells, and of therapeutic cells and tissues.
This includes discovering the underlying engineering principles that are needed to capture the responses of biological systems and bioreactors. It also includes the creation of novel biosensing platforms and new optical imaging and modulation strategies. Research that enables the design of biological systems to sense and respond to novel stimuli is welcome.
Similarly, projects leading to insight into tissue changes or injury, and to systems that imitate or restore the functions of tissues or organs are encouraged. Projects that advance rehabilitation engineering through new theories and approaches are supported by the EBBS program. Fundamental engineering research driven by the needs of persons with disabilities is encouraged.
The EBBS program expands what is possible in biomanufacturing; research may advance biotechnology and/or health. EBBS research must enable improved biological processes, create novel biomedical technologies, or achieve new understanding of physiological or pathological processes. EBBS does not support proposals with a main goal of drug design, drug delivery, or the development of animal models of disease.
Using existing models for experimental testing and validation is acceptable. Projects that focus on testing and validating therapies are not supported. Clinical trials are not supported.
Limited studies involving human volunteers may be supported if appropriate to the project objectives. Projects focused on commercialization are more appropriate for the NSF Directorate for Technology, Innovation, and Partnerships (TIP). Partnerships: To speed discovery and innovation, NSF partners with federal agencies, industry, international groups, and others.
Current opportunities are at NSF ENG Partnerships. Awards made through this program Browse projects funded by this program Map of recent awards made through this program Directorate for Engineering (ENG) Division of Chemical, Bioengineering, Environmental and Transport Systems (ENG/CBET)
According to the current listing, eligibility includes: See official notice. The EBBS program does not support proposals with a main goal of drug design, drug delivery, the development of animal models of disease, testing and validating therapies, or clinical trials. Confirm the full requirements in the official notice before applying.
Engineering Biological and Biomedical Systems (EBBS) is funded by U.S. National Science Foundation. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NSF obligated $6.4 billion across 6,218 awards in FY2026, down from $8.3 billion and 8,647. An August OMB apportionment carried $1.7 billion into FY2027, roughly $1 billion of it reserved for the White House Grand Research Challenges initiative. NIH, by contrast, spent its full $34 billion. Here is what the carryover mechanism actually means for your FY2027 proposal — and why the directorate you submit to now matters more than the score you get.
Read articleNSF 26-504 collapses PRFB's three competitive areas into a single AI-and-biotechnology focus area, raises the stipend to $85,000, and cuts the fellowship from 36 months to 24. The total award value fell 18.5 percent. The next deadline is September 28, 2027.
Read articleOn September 10, 2026 GAO sustained Battelle's protest of NSF's 20-year, $8 billion Antarctic Science and Engineering Support Contract because KBR's proposal never said what its affiliate would actually contribute. The holding generalizes far beyond Antarctica — to every proposal that borrows a parent or sister company's track record.
Read article